Cart summary

You have no items in your shopping cart.

Regadenoson

SKU: orb1225339

Description

Regadenoson is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number313348-27-5
MW390.35
Purity>98% (HPLC)
FormulaC15H18N8O5
SMILESCNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
TargetAdenosine Receptor
SolubilityDMSO: 10 mM

Bioactivity

In Vivo
Animal model: Mongrel dogs (23-27 kg). Dosage: 0.1, 0.175, 0.25, 0.5, 1.0, 2.5, 5 μg/kg. Administration: Peripheral intravenous injection; single. Result: Increased mean CBF (coronary blood flow) in a dose-dependent manner, with an ED50 of 0.34 μg/kg and resulted in a maximal increase of 154 mL/min from baseline (45 mL/min). Caused a dose-dependent decrease in mean coronary resistance with a maximal decrease of 73 and 75 % at 2.5 and 5 μg/kg, respectively. Animal model: Mongrel dogs (23-27 kg). Dosage: 2.5 μg/kg. Administration: Peripheral intravenous injection; single in 30 s. Result: Reached 84% of the peak reactive hyperemia flow following a 20-s-long coronary occlusion (201 mL/min). Animal model: Female F344 rats (150-170 g). Dosage: 0.5 μg/kg. Administration: Intravenous injection; single (60 or 90 min after Temozolomide administration). Result: Increaseed levels of Temozolomide by 60 % in normal brain without affecting plasma concentrations.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CVT-3146 | Lexiscan

Similar Products

  • Regadenoson [orb1305186]

    >99.99% (May vary between batches)

    313348-27-5

    390.35

    C15H18N8O5

    25 mg, 50 mg, 500 mg, 1 ml x 10 mM (in DMSO), 2 mg, 5 mg, 10 mg, 100 mg
  • Regadenoson hydrate [orb1701709]

    99.71% (May vary between batches)

    875148-45-1

    408.37

    C15H20N8O6

    1 mg
  • 1-epi-Regadenoson [orb1980211]

    2015222-31-6

    390.35

    C15H18N8O5

    5 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Regadenoson (orb1225339)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 80.00
5 mg
$ 100.00
10 mg
$ 140.00
25 mg
$ 250.00
50 mg
$ 370.00
100 mg
$ 540.00
500 mg
$ 1,170.00